Home Newsfeeds HC Wainwright & Co. Maintains Neutral on Intercept Pharmaceuticals, Lowers Price Target to $14

HC Wainwright & Co. Maintains Neutral on Intercept Pharmaceuticals, Lowers Price Target to $14

HC Wainwright & Co. analyst Ed Arce maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral and lowers the price target from $16 to $14.

byBenzinga Newsdesk

November 16, 2022

1 minute read

HC Wainwright & Co. analyst Ed Arce maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral and lowers the price target from $16 to $14.

Insiders Buying Turtle Beach And 3 Other Stocks

By Avi Kapoor

May 17, 8:39 AM

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares,…

ARKR

Stephens & Co. Maintains Equal-Weight on National Bank Holdings, Raises Price Target to $47

By Benzinga Newsdesk

October 31, 9:53 AM

Stephens & Co. analyst Andrew Terrell maintains National Bank Holdings (NYSE:NBHC) with a Equal-Weight and raises the price target from $45 to $47.

NBHC

Just DON’T Do it! As The Dollar Get Stronger, Nike’s Earnings Get Weaker

By AJ Fabino

September 26, 3:17 PM

The U.S. Dollar Index (DXY), which measures the strength of the dollar against a host of major currencies, is reaching 20-year highs and that's bad news for businesses like Nike Inc (NYSE: NKE), which releases earnings on Thursday.

NFLX

Why JPMorgan Shares Are Surging Today

By Akanksha Bakshi

July 14, 8:09 AM

JPMorgan Chase & Co (NYSE: JPM) reported Q2 net revenue (managed) of $42.4 billion, up 34.1% year-over-year, beating the consensus of $38.96 billion.

JPM

HC Wainwright & Co. Maintains Neutral on Intercept Pharmaceuticals, Lowers Price Target to $14

Related Posts

Insiders Buying Turtle Beach And 3 Other Stocks

Stephens & Co. Maintains Equal-Weight on National Bank Holdings, Raises Price Target to $47

Just DON’T Do it! As The Dollar Get Stronger, Nike’s Earnings Get Weaker

Why JPMorgan Shares Are Surging Today